Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 721 to 735 of 2042 results for guidelines

  1. Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I (DG32)

    Evidence-based recommendations on 2 adjunctive colposcopy technologies (the DYSIS colposcope with DYSISmap and the ZedScan I) for assessing suspected cervical abnormalities in people having colposcopy

  2. Patiromer for treating hyperkalaemia (TA623)

    Evidence based recommendations on patiromer (Veltassa) for treating hyperkalaemia in adults.

  3. Involving you in the development of our guidance

    There are a number of ways you can get involved in the development of our guidance.

  4. Guidance on the use of trastuzumab for the treatment of advanced breast cancer (TA34)

    Evidence-based recommendations on trastuzumab for treating advanced breast cancer in adults.

  5. Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care (DG56)

    Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care

  6. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (TA47)

    Evidence-based recommendations on glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban) for treating acute coronary syndromes in adults.

  7. Supporting people who provide unpaid care for adults with health or social care needs

    NICE guideline Supporting adult carers (QS200) – NICE quality standard People's experience in adult social care services (NG86) – NICE...

  8. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)

    Evidence-based recommendations on continuous subcutaneous insulin infusion (insulin pump therapy) for treating type 1 diabetes in adults and children.

  9. Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)

    Evidence-based recommendations on biomarker tests to help diagnose preterm labour in women with intact membranes. The tests are Actim Partus, PartoSure and the Rapid fetal fibronectin (fFN) 10Q Cassette Kit (at thresholds other than 50 nanograms/millilitre)

  10. Myocardial infarction: medication for MI more than 12 months ago (IND126)

    This indicator covers the percentage of patients with a history of myocardial infarction (more than 12 months ago) who are currently being treated with an ACE-I (or ARB if ACE-I intolerant), aspirin (or clopidogrel, or anticoagulant drug therapy) and a statin, and a beta-blocker for those patients with left ventricular systolic dysfunction. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM80

  11. Understanding intermediate care, including reablement

    A guide to intermediate care services that provide support for a short time to help you recover and increase your independence

  12. Moving between hospital and home, including care homes

    NICE quick guide - moving between hospital and home, including care homes

  13. Using our guidance

    Support for voluntary and community sector organisations using NICE guidance

  14. What to expect during assessment and care planning

    A quick guide for people using adult social care services.

  15. Asthma. Patient decision aid on asthma inhalers and climate change

    Intercollegiate Guidelines Network (SIGN) and the British Thoracic Society (BTS) to environmental sustainability. It is consistent with...